ScholarIQanswers from OpenAlex

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients

PaperCitations, authors & open-access status

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients have?

ScholarIQcitation count

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients has 155 citations in the OpenAlex counts ScholarIQ stores.

When was Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients published?

ScholarIQyear

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients has 2020 year in the ScholarIQ index.

What is the open-access status of Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients?

ScholarIQoa status

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients has green oa status in the ScholarIQ index.

What is the DOI of Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients?

ScholarIQdoi

The DOI for Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients is on the source record.

What is the PMID of Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients?

ScholarIQpmid

The PMID for Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients is on the source record.

What is the OpenAlex record for Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients?

ScholarIQopenalex

The OpenAlex for Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial